DK1285659T3 - Anvendelse af clarithromycin til fremstilling af et lægemiddel til behandlingen af arthritis deformans - Google Patents

Anvendelse af clarithromycin til fremstilling af et lægemiddel til behandlingen af arthritis deformans

Info

Publication number
DK1285659T3
DK1285659T3 DK01119436T DK01119436T DK1285659T3 DK 1285659 T3 DK1285659 T3 DK 1285659T3 DK 01119436 T DK01119436 T DK 01119436T DK 01119436 T DK01119436 T DK 01119436T DK 1285659 T3 DK1285659 T3 DK 1285659T3
Authority
DK
Denmark
Prior art keywords
clarithromycin
treatment
drug
manufacture
arthritis deformans
Prior art date
Application number
DK01119436T
Other languages
Danish (da)
English (en)
Inventor
Gianantonio Saviola
Original Assignee
Fond Salvatore Maugeri Clinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Salvatore Maugeri Clinica filed Critical Fond Salvatore Maugeri Clinica
Application granted granted Critical
Publication of DK1285659T3 publication Critical patent/DK1285659T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK01119436T 2001-08-13 2001-08-13 Anvendelse af clarithromycin til fremstilling af et lægemiddel til behandlingen af arthritis deformans DK1285659T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01119436A EP1285659B1 (de) 2001-08-13 2001-08-13 Verwendung von Clarithromycin zur Herstellung eines Medikaments für die Behandlung von Arthrosis deformans

Publications (1)

Publication Number Publication Date
DK1285659T3 true DK1285659T3 (da) 2007-10-29

Family

ID=8178305

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01119436T DK1285659T3 (da) 2001-08-13 2001-08-13 Anvendelse af clarithromycin til fremstilling af et lægemiddel til behandlingen af arthritis deformans

Country Status (7)

Country Link
EP (1) EP1285659B1 (de)
AT (1) ATE365557T1 (de)
DE (1) DE60129133T2 (de)
DK (1) DK1285659T3 (de)
ES (1) ES2288898T3 (de)
PT (1) PT1285659E (de)
SI (1) SI1285659T1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2219659C (en) * 1995-06-09 2008-03-18 Novartis Ag Rapamycin derivatives
AU3501700A (en) * 1999-02-26 2000-09-14 Human Genome Sciences, Inc. Human endokine alpha and methods of use
TR200000054A2 (tr) * 2000-01-05 2001-08-21 Sanovel İlaç San. Ve Ti̇c. Anoni̇m Şi̇rketi̇ Klaritromisin içeren sürekli salım sağlayan tablet formülasyonları.
CA2397092A1 (en) * 2000-01-11 2001-07-19 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs

Also Published As

Publication number Publication date
DE60129133T2 (de) 2008-03-06
EP1285659A1 (de) 2003-02-26
PT1285659E (pt) 2007-10-09
EP1285659B1 (de) 2007-06-27
DE60129133D1 (de) 2007-08-09
ATE365557T1 (de) 2007-07-15
SI1285659T1 (sl) 2008-02-29
ES2288898T3 (es) 2008-02-01

Similar Documents

Publication Publication Date Title
BR0205721A (pt) Formulações de oximorfona de liberação controlada
NO20033556L (no) Farmasöytiske formuleringer
ATE296619T1 (de) Feste orale dosierungsform von simethicon
ATE540678T1 (de) Prodrugs aus gaba-analoga, zusammensetzungen und ihre verwendungen
DK1353668T3 (da) Fremgangsmåder til fremstillingen af farmaceutiske sammensætninger, der indeholder epothilonanaloger, til behandlingen af cancer
FI20011478A (fi) Farmaseuttinen koostumus
NO20040125L (no) Enterale formuleringer
NO20033384L (no) Farmasoytisk formulering
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
EE200300416A (et) Ravimvorm
DK1448205T3 (da) Kombinationer til behandling af immunoinflammatoriske sygdomme
EE200300537A (et) Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
EE200300589A (et) Ravimkoostised
NO20035627D0 (no) Farmasöytisk formulering
SE0203825D0 (sv) Novel fused heterocycles and uses thereof
DK1458413T3 (da) Farmaceutiske sammensætninger på b asis af azetidin-derivater
FI20022128A (fi) Farmaseuttinen koostumus
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DK1475379T3 (da) Anvendelse af scopinesterderivater til fremstilling af lægemidler
DK1133997T3 (da) Beta-interferon til behandling af immunsygdomme
DK1285659T3 (da) Anvendelse af clarithromycin til fremstilling af et lægemiddel til behandlingen af arthritis deformans
DK1385512T3 (da) Anvendelse af pyridoindolonderivater til fremstilling af anticancerlægemidler
DK2105135T3 (da) Farmaceutiske sammensætninger til behandling af cancer
PT102642A (pt) Composicao farmaceutica de dosagem unica diaria contendo brivudine
IT1320253B1 (it) Composizione farmaceutica per il trattamento della malaria.